Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Patient characteristics, by protocol

From: Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study

 

Total

4-Day

7-Day

N = 126

N = 54

N = 72

Age

37(10)

36(9)

38(11)

Gender

   

Woman

33 (26%)

16 (30%)

17 (24%)

Man

90 (71%)

38 (70%)

52 (72%)

Non-binary

3 (2%)

0 (0%)

3 (4%)

Race/ethnicity

   

Black or African American

26 (21%)

10 (19%)

16 (22%)

Latine

20 (16%)

7 (13%)

13 (18%)

White

66 (52%)

31 (57%)

35 (49%)

Other

13 (10%)

6 (11%)

7 (10%)

Unknown or not available

1 (1%)

0 (0%)

1 (1%)

Primary insurance

   

Medicaid

94 (75%)

45 (83%)

49 (68%)

Medicare

8 (6%)

1 (2%)

7 (10%)

Uninsured

8 (6%)

4 (7%)

4 (6%)

Other

16 (13%)

4 (7%)

12 (17%)

Housing status

   

Stably housed

47 (37%)

18 (33%)

29 (40%)

Transitionally or temporarily housed

44 (35%)

17 (31%)

27 (38%)

Unsheltered

32 (25%)

17 (31%)

15 (21%)

Unknown or not available

3 (2%)

2 (4%)

1 (1%)

Medical and psychiatric history

   

Chronic pain

33 (26%)

18 (33%)

15 (21%)

Depression

53 (42%)

24 (44%)

29 (40%)

Bipolar disorder

21 (17%)

8 (15%)

13 (18%)

Anxiety disorder (GAD, OCD, PTSD)

56 (44%)

21 (39%)

35 (49%)

ADD/ADHD

17 (13%)

5 (9%)

12 (17%)

Psychosis

25 (20%)

6 (11%)

19 (26%)

Substance co-use in the past 3 months

   

Alcohol

24 (19%)

9 (17%)

15 (21%)

Benzodiazepine

28 (22%)

12 (22%)

16 (22%)

Amphetamines

93 (74%)

35 (65%)

58 (81%)

Cocaine

37 (29%)

22 (41%)

15 (21%)

Opioid use in the past 3 months in addition to fentanyl

  

Opioid pills

2 (2%)

0 (0%)

2 (3%)

Heroin

31 (25%)

12 (22%)

19 (26%)

Primary route of opioid use in past 3 months

  

Injection (IV/IM)

13 (10%)

6 (11%)

7 (10%)

Inhaled (smoked)

99 (79%)

41 (76%)

58 (81%)

Intranasal (snorted)

5 (4%)

2 (4%)

3 (4%)

Unknown or not available

9 (7%)

5 (9%)

4 (6%)

History of drug overdose

83 (66%)

38 (70%)

45 (62%)

Prior buprenorphine treatment

87 (71%)

34 (64%)

53 (76%)